Skip to content
HomeLatest newsJohnson & Johnson teams up with the Ad Council to cheer on diversity
Love Has No Labels Banner

Johnson & Johnson teams up with the Ad Council to cheer on diversity

This Valentine’s Day, the company is supporting the Love Has No Labels campaign to help spread the word about embracing equality, inclusion—and love.

You don’t need a foam finger or a felt pennant to show you’re a fan. A fan of love, that is.

Johnson & Johnson has been a fan of love for more than 130 years. Diversity, inclusion and equality are at the heart of everything we do—from our commitment to helping employees grow personally and professionally to our products and innovations that deliver care around the world.

This culture of belonging and open-mindedness dates back to our company Credo, which was written back in 1943 and guides our decision-making to this day.

So it was a no-brainer for us to team up recently with the Ad Council, as part of their Love Has No Labels campaign, to help turn the “kiss cam”—a fan favorite at sporting events—into a symbol for unbiased love at the 2017 NFL Pro Bowl in Orlando.

Check out the below video to watch the playful game day experiment in action.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.